نتایج جستجو برای: refractory nhl lymphoma

تعداد نتایج: 155852  

Journal: :European review for medical and pharmacological sciences 2014
C Cao S Liu S-F Lou T Liu

BACKGROUND AND OBJECTIVES Many studies have shown that the +252A/G polymorphism in the lymphotoxin-α gene is implicated in susceptibility to non-Hodgkin lymphoma but with considerable variance of results. This study aimed to clarify the overall association between the +252A/G polymorphism in the lymphotoxin-α gene and non-Hodgkin lymphoma (NHL) risk by performing a meta-analysis. MATERIALS AN...

2016
Dinkar Desai Siddharth Pandit Shiny Jasphin Akhil S. Shetty

Non-Hodgkin's lymphoma (NHL) is the third common malignant lesion of the oral region. Plasmablastic lymphomas are rare, aggressive neoplasms occurring mostly in human immunodeficiency virus (HIV) infected individual which accounts for approximately 2.6% of all NHL. It usually presents as a diffuse growth and with diffuse pattern of histological presentation. It is very difficult to differentiat...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007
Christine F Skibola

Non-Hodgkin lymphoma (NHL) represents a group of heterogeneous diseases that significantly vary in their causes, molecular profiles, and natural progression. In 2007, there will be approximately 59,000 newly diagnosed NHL cases in the United States and over 300,000 cases worldwide. Although new therapeutic regimens are minimizing the number of deaths related to NHL, causes for the majority of l...

Journal: :Seminars in hematology 2011
Mathias J Rummel Stephanie A Gregory

The potent alkylating agent bendamustine has demonstrated substantial efficacy in patients with non-Hodgkin lymphomas (NHLs), including chronic lymphocytic leukemia (CLL), follicular lymphoma, and mantle cell lymphoma. Due to incomplete cross-reactivity between bendamustine and other chemotherapeutic agents, bendamustine has been extensively tested in the relapsed/refractory setting. Bendamusti...

Journal: :Annals of the rheumatic diseases 2007
B Löfström C Backlin C Sundström A Ekbom I E Lundberg

OBJECTIVE To investigate risk factors for non-Hodgkin's lymphoma (NHL) and analyse NHL subtypes and characteristics in patients with systemic lupus erythematosus (SLE). METHODS A national SLE cohort identified through SLE discharge diagnoses in the Swedish hospital discharge register during 1964 to 1995 (n = 6438) was linked to the national cancer register. A nested case control study on SLE ...

Journal: :JPMA. The Journal of the Pakistan Medical Association 1999
I Mehdi

Adult Non-Hodgkin’s Lymphoma (NHL) is a diverse group of lymphoid malignancies, with an increasing annual trend world over. NHL has shGwn an increase by 39% in Caucasians and 46% in black population and is at least three times more frequent than Hodgkin’s disease, as shown by the SEER study.Intermediate grade lymphoma still constitutes the largest proportion of NHL. Increased incidenceof NHL is...

2014
Unhee Lim Jonathan M. Kocarnik William S. Bush Tara C. Matise Christian Caberto Sungshim Lani Park Christopher S. Carlson Ewa Deelman David Duggan Megan Fesinmeyer Christopher A. Haiman Brian E. Henderson Lucia A. Hindorff Laurence N. Kolonel Ulrike Peters Daniel O. Stram Maarit Tiirikainen Lynne R. Wilkens Chunyuan Wu Charles Kooperberg Loïc Le Marchand

BACKGROUND Risk of non-Hodgkin lymphoma (NHL) is higher among individuals with a family history or a prior diagnosis of other cancers. Genome-wide association studies (GWAS) have suggested that some genetic susceptibility variants are associated with multiple complex traits (pleiotropy). OBJECTIVE We investigated whether common risk variants identified in cancer GWAS may also increase the ris...

Journal: :Leukemia research 1991
L M Pottern M Linet A Blair F Dick L F Burmeister R Gibson L M Schuman J F Fraumeni

To investigate whether a history of hematolymphoproliferative cancers (HLP) and other cancers among a parent or sibling is a risk factor for specific subtypes of leukemia and non-Hodgkin's lymphoma (NHL), data from a population-based case-control study, in Iowa and Minnesota, of 578 leukemia cases, 622 NHL cases and 1245 controls were evaluated. Having at least one sibling with HLP significantl...

Journal: :Hematological Oncology 2023

Background: Preclinical trial has demonstrated that sequential use of Selinexor and Anti-CD19 directed chimeric antigen receptor modified T-Cell therapy (CART19) cells might improve the anti-tumor efficacy CART 19 against lymphoma cells. However, safety CART19 combined with in patients is unknown. We report preliminary data from a phase 2 relapsed or refractory B-cell non-Hodgkin (R/R B-NHL). M...

2014
Marko Erak Milana Mitric

Lymphoma of the orbit is a rare presentation of nonHodgkin’s lymphoma (NHL). According to the data from the literature, orbital lymphoma represents 8% of all extranodal NHL and about 1% of all NHL [1-3]. Symptoms which are usually caused by orbital lymphoma are proptosis, periorbital swelling, conjunctival (salmonpink) swelling, diplopia, and conjunctival redness and irritation [4]. Radiotherap...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید